Extendicare reported robust growth and strategic expansion through acquisitions, which strengthened its position in the long-term and home care sectors. Despite some challenges such as increased operating costs due to seasonal factors and a decline in the Managed Services segment, the overall performance and future growth prospects indicate a positive outlook.

Company Guidance

During Extendicare Inc.'s second quarter 2025 conference call, the company provided guidance reflecting strong financial performance and strategic growth initiatives. Adjusted EBITDA increased by 3% to $39.8 million compared to the prior year, with a significant 15.4% rise when excluding out-of-period items, largely driven by a 10.9% increase in average daily volumes in the home health care segment. The company reported a net operating income (NOI) margin improvement of 90 basis points to 13.5%, attributed to efficient capital allocation and scalable back-office operations. Extendicare highlighted notable acquisitions, including the purchase of nine long-term care homes from Revera, adding 822 beds with an expected annualized NOI contribution of $13 million. Additionally, the acquisition of Closing the Gap for $75.1 million is anticipated to contribute $9.8 million in annualized NOI. The company's available liquidity position was strengthened with an increase in its senior secured credit facility by $100 million, maintaining a favorable position for future strategic acquisitions. Moreover, Extendicare mentioned ongoing redevelopment projects and a new capital funding policy by the Ontario government, which provides greater funding flexibility for long-term care home construction. These efforts align with Extendicare's commitment to expanding long-term care capacity in response to demographic demand, while maintaining a dividend payout ratio of 46% and an AFFO increase of 23.1% year-over-year to $0.29 per share.

Strong Organic Growth and Improved Margins

Adjusted EBITDA increased to $39.8 million, up 3% over the prior year. Excluding out-of-period items, adjusted EBITDA increased by 15.4% with home health care leading the way. Average daily volumes were up 10.9% from the prior year, and NOI margin improved by 90 basis points to 13.5%.

Strategic Acquisitions and Expansion

Extendicare closed the acquisition of 9 Class C long-term care homes and a parcel of land for $41.9 million, adding 822 long-term care beds and 574 private pay retirement beds. Additionally, the acquisition of Closing the Gap for $75.1 million added more than 1,200 caregivers and 1.1 million service hours to the home health segment.

Increase in AFFO and Dividend Payout Ratio

AFFO increased to $0.29 per share, up 23.1% year-over-year, with a dividend payout ratio of 46% on a trailing 12-month basis.

Enhanced Liquidity Position

Senior secured credit facility increased by $100 million, leaving Extendicare in a strong liquidity position with $152 million available on the revolver and $73 million cash on hand at quarter end.

Extendicare (TSE:EXE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:EXE Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 12, 2025	2025 (Q3)	0.20 / -	0.19	―	―	―
Aug 06, 2025	2025 (Q2)	0.18 / 0.37	0.29	28.62% (+0.08)	―	―
May 06, 2025	2025 (Q1)	0.16 / 0.18	0.15	17.33% (+0.03)	―	―
Feb 27, 2025	2024 (Q4)	0.17 / 0.23	0.1	130.00% (+0.13)	―	―
Nov 12, 2024	2024 (Q3)	- / 0.19	0.14	35.71% (+0.05)	―	―
Aug 12, 2024	2024 (Q2)	- / 0.29	0.02	1350.00% (+0.27)	―	―
May 15, 2024	2024 (Q1)	- / 0.15	0.14	7.14% (<+0.01)	―	―
Mar 08, 2024	2023 (Q4)	- / 0.10	-0.09	211.11% (+0.19)	―	―
Nov 09, 2023	2023 (Q3)	- / 0.14	-0.04	450.00% (+0.18)	―	―
Aug 10, 2023	2023 (Q2)	- / 0.02	0.04	-50.00% (-0.02)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:EXE Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	C$12.65	C$12.62	-0.24%
May 06, 2025	C$14.37	C$13.52	-5.92%
Feb 27, 2025	C$11.37	C$12.18	+7.12%
Nov 12, 2024	C$9.16	C$9.84	+7.42%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Extendicare (TSE:EXE) report earnings?

Extendicare (TSE:EXE) is schdueled to report earning on Nov 12, 2025, After Close (Confirmed).

What is Extendicare (TSE:EXE) earnings time?

Extendicare (TSE:EXE) earnings time is at Nov 12, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:EXE EPS forecast?

TSE:EXE EPS forecast for the fiscal quarter 2025 (Q3) is 0.2.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing